Trial Profile
Efficacy and Safety of Lesogaberan (AZD3355) in Chinese Patients With Reflux Symptoms Refractory to Proton Pump Inhibitor Therapy: a Randomized Placebo-controlled Trial
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Jun 2018
Price :
$35
*
At a glance
- Drugs Lesogaberan (Primary)
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- 11 Jul 2016 New trial record